Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Cvirn, G; Hoerl, G; Tafeit, E; Heinl, N; Wodrig, K; Wagner, T; Koestenberger, M; Juergens, G.
Effects of Nadroparin, Enoxaparin, and Unfractionated Heparin on Endogenous Formation of Factor Xa and IIa and on Thrombelastometry Profiles in Cord versus Adult Blood.
Neonatology. 2011; 100(1): 23-31.
Doi: 10.1159/000320164
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Cvirn Gerhard
- Co-Autor*innen der Med Uni Graz
- Hörl Gerd
- Jürgens Günther
- Koestenberger Martin
- Tafeit Erwin
- Wagner Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background: To date, only few pharmacokinetic studies on low-molecular-weight heparins (LMWHs) in neonates exist not allowing to formally assess pharmacodynamics of LMWHs in neonates. Objective: To evaluate the anticoagulant effects of the two LMWHs nadroparin and enoxaparin on endogenous formation of FXa or FIIa in cord versus adult platelet-poor plasma (PPP) and on thrombelastometry profiles in cord versus adult whole blood (WB). Unfractionated heparin (UH) was the reference antithrombotic drug. Methods: The effects of nadroparin, enoxaparin, or UH on endogenous formation of FXa or FIIa was investigated in tissue factor-activated PPP using a subsampling technique and chromogenic substrates. The anticoagulant efficacy of these drugs was also investigated in WB triggered by the physiological relevant activator collagen/endogenous thrombin using thrombelastometry. Results: The major findings are (i) nadroparin is as efficient as enoxaparin concerning inhibition of the endogenous formation of FXa and FIIa, (ii) cord PPP and WB are significantly more susceptible to the addition of LMWHs or UH than adult PPP or WB, and (iii) compared by equivalent anti-FXa activity, the anticoagulant action of UH is markedly higher than that of the LMWHs in PPP and WB of neonatal or adult origin. Conclusions: Administration of LMWHs in neonates has to be performed carefully to avoid bleeding side effects due to their high anticoagulant efficacy in cord PPP and WB. Copyright (C) 2010 S. Karger AG, Basel
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Anticoagulants - pharmacology
- Blood Coagulation - drug effects
- Drug Evaluation, Preclinical -
- Enoxaparin - pharmacology
- Factor Xa - metabolism
- Fetal Blood - drug effects
- Fibrinolytic Agents - pharmacology
- Heparin - pharmacology
- Humans -
- Infant, Newborn -
- Middle Aged -
- Nadroparin - pharmacology
- Prothrombin - metabolism
- Thrombelastography -
- Thrombin - metabolism
- Young Adult -
- Find related publications in this database (Keywords)
- Endogenous FXa and FIIa formation
- Thrombelastometry
- Low-molecular-weight heparin
- Unfractionated heparin